2022 HAN Messages
- 0484 – 12/22/2022
Increase in Pediatric Invasive Group A Streptococcal Infections - 0483 – 12/20/2022
Important Updates on COVID-19 Therapeutics for Treatment and Prevention - 0482 – 12/14/2022
Interim Guidance for Clinicians to Prioritize Antiviral Treatment of Influenza in the Setting of Reduced Availability of Oseltamivir - 0481 – 11/17/2022
Update on Managing Monkeypox in Patients Receiving Therapeutics - 0480 – 11/07/2022
Update on Ebola Virus Disease (Sudan ebolavirus) Outbreak in Central Uganda - 0479 – 11/04/2022
Increased Respiratory Virus Activity, Especially Among Children, Early in the 2022-2023 Fall and Winter - 0478 – 10/31/2022
Outbreaks of Nontuberculous Mycobacteria Infections Highlight Importance of Maintaining and Monitoring Dental Waterlines - 0477 – 10/06/2022
Outbreak of Ebola virus disease (Sudan ebolavirus) in Central Uganda - 0476 – 10/01/2022
Hurricanes Fiona and Ian—Clinical Guidance for Carbon Monoxide (CO) Poisoning - 0475 – 09/29/2022
Severe Manifestations of Monkeypox among People who are Immunocompromised Due to HIV or Other Conditions - 0474 – 09/09/2022
Severe Respiratory Illnesses Associated with Rhinoviruses and/or Enteroviruses Including EV-D68 – Multistate, 2022 - 0473 – 08/30/2022
Variant Influenza Virus Infections: Recommendations for Identification, Treatment, and Prevention for Summer and Fall 2022 - 0472 – 07/30/2022
Update for Clinicians on Monkeypox in People with HIV, Children and Adolescents, and People who are Pregnant or Breastfeeding - 0471 – 07/28/2022
Update for Clinicians on Testing and Treatment for Monkeypox - 0470 – 07/27/2022
Melioidosis Locally Endemic in Areas of the Mississippi Gulf Coast after Burkholderia pseudomallei Isolated in Soil and Water and Linked to Two Cases – Mississippi, 2020 and 2022 - 0469 – 07/12/2022
Recent Reports of Human Parechovirus (PeV) in the United States—2022 - 0468 – 06/14/2022
Updated Case-finding Guidance: Monkeypox Outbreak—United States, 2022 - 0467 – 05/24/2022
COVID-19 Rebound After Paxlovid Treatment - 0466 – 05/20/2022
Monkeypox Virus Infection in the United States and Other Non-endemic Countries—2022 - 0465 – 05/11/2022
Updated Recommendations for Adenovirus Testing and Reporting of Children with Acute Hepatitis of Unknown Etiology - 0464 – 04/28/2022
Highly Pathogenic Avian Influenza A(H5N1) Virus: Recommendations for Human Health Investigations and Response - 0463 – 04/25/2022
Updated Information on Availability and Use of Treatments for Outpatients with Mild to Moderate COVID-19 Who are at Increased Risk for Severe Outcomes of COVID-19 - 0462 – 04/21/2022
Recommendations for Adenovirus Testing and Reporting of Children with Acute Hepatitis of Unknown Etiology
Additional Resources